As biotechnology industry expands, so does the need for strategic marketing approaches to reach investors, regulatory bodies, healthcare providers, and consumers…read more
The biotechnology industry is experiencing rapid advancements in gene editing, personalized medicine, synthetic biology, and biopharmaceuticals. As the industry expands,…
The Federal Circuit recently reversed a $4.7M verdict in a patent lawsuit involving two patents concerning next-generation sequencing methods—U.S. Patent…
On August 11, 2025, the Federal Circuit reversed the District of Utah’s ruling that all but one of the claims…
The Federal government is accelerating AI‑enabled innovation by launching the Genesis Mission, a sweeping national initiative to accelerate scientific discovery…
The U.S. gave crypto one of its biggest regulatory jolts in years. With the signing of the Guiding and Establishing…
In mid-November 2025, Congress introduced the Biomanufacturing Excellence Act of 2025 (H.R. 6089) to establish a dedicated national center aimed…
Method-of-treatment (“MoT”) claims can be powerful tools for pharmaceutical companies seeking to extend market exclusivity for their products after the…
Sign in to your account